These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
900 related articles for article (PubMed ID: 15573291)
1. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy]. Lubienski A; Bitsch RG; Schemmer P; Grenacher L; Düx M; Kauffmann GW Rofo; 2004 Dec; 176(12):1794-802. PubMed ID: 15573291 [TBL] [Abstract][Full Text] [Related]
2. [Long-term result of combination of transcatheter arterial chemoembolization and percutaneous ethanol injection for treatment of hepatocellular carcinoma]. Chen XM; Luo PF; Lin HH; Zhou ZJ; Shao PJ; Fu L; Li WK Ai Zheng; 2004 Jul; 23(7):829-32. PubMed ID: 15248922 [TBL] [Abstract][Full Text] [Related]
3. Transcatheter arterial chemoembolization therapy combined with percutaneous ethanol injection for unresectable large hepatocellular carcinoma: an evaluation of the local therapeutic effect and survival rate. Dohmen K; Shirahama M; Shigematsu H; Miyamoto Y; Torii Y; Irie K; Ishibashi H Hepatogastroenterology; 2001; 48(41):1409-15. PubMed ID: 11677976 [TBL] [Abstract][Full Text] [Related]
4. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Bartolozzi C; Lencioni R; Caramella D; Vignali C; Cioni R; Mazzeo S; Carrai M; Maltinti G; Capria A; Conte PF Radiology; 1995 Dec; 197(3):812-8. PubMed ID: 7480761 [TBL] [Abstract][Full Text] [Related]
5. Percutaneous treatment of hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts. Tesdal IK; Wikström M; Flechtenmacher C; Filser T; Dueber C Cardiovasc Intervent Radiol; 2006; 29(5):778-84. PubMed ID: 16779690 [TBL] [Abstract][Full Text] [Related]
6. A comparison of chemoembolization with conventional chemotherapy and symptomatic treatment in cirrhotic patients with hepatocellular carcinoma. Bayraktar Y; Balkanci F; Kayhan B; Uzunalimoglu B; Gokoz A; Ozisik Y; Gurakar A; Van Thiel DH; Firat D Hepatogastroenterology; 1996; 43(9):681-7. PubMed ID: 8799415 [TBL] [Abstract][Full Text] [Related]
7. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269 [TBL] [Abstract][Full Text] [Related]
8. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115 [TBL] [Abstract][Full Text] [Related]
9. [Combined treatment of hepatocarcinoma with chemoembolization and alcohol administration. Long-term results]. Bartolozzi C; Lencioni R; Armillotta N Radiol Med; 1997; 94(1-2):19-23. PubMed ID: 9424645 [TBL] [Abstract][Full Text] [Related]
10. [Combined percutaneous ethanol injection through liver puncture and transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma]. Li C; Shi Z; Hao Y Zhonghua Zhong Liu Za Zhi; 2001 Nov; 23(6):490-2. PubMed ID: 11859718 [TBL] [Abstract][Full Text] [Related]
11. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Zhang Z; Liu Q; He J; Yang J; Yang G; Wu M Cancer; 2000 Dec; 89(12):2606-12. PubMed ID: 11135222 [TBL] [Abstract][Full Text] [Related]
12. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Wang W; Shi J; Xie WF Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507 [TBL] [Abstract][Full Text] [Related]
13. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma]. Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577 [TBL] [Abstract][Full Text] [Related]
14. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y; Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600 [TBL] [Abstract][Full Text] [Related]
15. Treatment of large hepatocellular carcinoma: comparison between techniques and long term results. Ferrari FS; Stella A; Gambacorta D; Magnolfi F; Fantozzi F; Pasquinucci P; Civeli L; Pieraccini M Radiol Med; 2004 Oct; 108(4):356-71. PubMed ID: 15525889 [TBL] [Abstract][Full Text] [Related]
16. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)]. De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241 [TBL] [Abstract][Full Text] [Related]
17. The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study. Yu Y; Lang Q; Chen Z; Li B; Yu C; Zhu D; Zhai X; Ling C Cancer; 2009 Nov; 115(22):5132-8. PubMed ID: 19672999 [TBL] [Abstract][Full Text] [Related]
18. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions. Wakabayashi H; Ushiyama T; Ishimura K; Izuishi K; Karasawa Y; Masaki T; Watanabe S; Kuriyama S; Maeta H J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065 [TBL] [Abstract][Full Text] [Related]
19. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Andriulli A; de Sio I; Solmi L; De Carlis L; Troisi R; Grasso A; Festa V; Caturelli E; Giacomoni A; Del Vecchio Blanco C; De Hemptinne B; Burroughs A; Perri F Liver Transpl; 2004 Nov; 10(11):1355-63. PubMed ID: 15497162 [TBL] [Abstract][Full Text] [Related]
20. Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of two kinds of dosages of anticancer drugs and analysis of prognostic factors. Lu W; Li Y; He X; Chen Y Hepatogastroenterology; 2003; 50(54):2079-83. PubMed ID: 14696468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]